Fulgent Genetics Balance Sheet
NASDAQ: FLGTHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Fulgent Genetics financial position
At the end of fiscal 2025, Fulgent Genetics reported total assets of $1.21 billion, down 0.5% from a year earlier against total liabilities of $106.8 million. Shareholders' equity stood at $1.11 billion, or 91.6% of assets. The company held $50.2 million in cash and equivalents against $2.0 million of debt, a net cash position of $48.2 million.
The current ratio (current assets divided by current liabilities) was 6.48, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.00.
Summary generated from market data by MetaCap's automated system. Methodology
Fulgent Genetics balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 50.19M | 55.14M | 97.47M | 79.51M | 164.89M | 87.43M | 11.96M | 6.74M | 6.49M | 7.90M |
| Short-Term Investments | 285.88M | 202.96M | — | — | — | 211.94M | 16.30M | 24.30M | 19.99M | 12.97M |
| Receivables | 84.76M | 69.02M | 51.13M | 52.75M | 138.91M | 183.86M | 6.55M | 5.95M | 4.00M | 4.36M |
| Total Current Assets | 550.49M | 353.57M | 507.85M | 627.87M | 611.96M | 523.62M | 37.08M | 39.54M | 32.93M | 26.14M |
| Property, Plant & Equipment | 112.55M | 105.55M | 83.46M | 81.35M | 62.29M | 40.20M | 5.97M | 6.45M | 7.27M | 6.23M |
| Goodwill | 25.08M | 22.05M | 22.05M | 143.03M | 50.90M | — | — | — | — | — |
| Intangible Assets | 133.28M | 134.98M | 143.05M | 150.64M | 35.91M | — | — | — | — | — |
| Long-Term Investments | 369.27M | 570.35M | 423.57M | 326.65M | 485.05M | 132.50M | 41.95M | 6.39M | 14.88M | — |
| Total Assets | 1.21B | 1.22B | 1.24B | 1.39B | 1.28B | 700.46M | 88.76M | 53.90M | 57.18M | 58.04M |
| Accounts Payable | 18.65M | 18.36M | 15.36M | 23.09M | 20.49M | 26.49M | 1.58M | 1.31M | 2.09M | 2.76M |
| Total Current Liabilities | 84.97M | 72.90M | 73.02M | 88.11M | 105.31M | 130.12M | 3.72M | 2.74M | 3.00M | 3.32M |
| Long-Term Debt | 1.96M | 2.49M | 2.96M | 3.37M | — | — | — | — | — | — |
| Total Liabilities | 106.81M | 90.81M | 102.04M | 116.18M | 112.84M | 131.07M | 5.98M | 2.75M | 3.01M | 3.56M |
| Shareholders' Equity | 1.11B | 1.13B | 1.14B | 1.27B | 1.16B | 569.39M | 82.78M | 51.15M | 54.18M | 54.48M |
| Retained Earnings | 529.95M | 590.47M | 633.17M | 801.00M | 657.60M | 150.88M | -63.43M | -63.02M | -57.66M | -55.15M |
| Total Debt | 1.96M | 2.49M | 2.96M | 3.37M | — | — | — | — | — | — |
| Net Cash (Debt) | 334.12M | 255.61M | 94.51M | 76.13M | 164.89M | 299.37M | 28.27M | 31.03M | 26.48M | 20.87M |
| Shares Outstanding | 31.08M | 30.84M | 29.65M | 29.44M | 30.16M | 28.18M | 21.48M | 18.17M | 17.85M | 17.68M |
This table shows 10 annual periods of Fulgent Genetics's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow FLGT's reporting calendar. What is a balance sheet?